Remission of procainamide-induced lupus erythematosus with N-acetylprocainamide therapy.
D000974:Antibodies, Antinuclear / Q000032:analysis; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced* / Q000276:immunology; D008297:Male; D008875:Middle Aged; D011342:Procainamide / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000974:Antibodies, Antinuclear; D011342:Procainamide